Published: May 14, 2021, 04:00 IST | Updated: May 14, 2021, 04:00 IST
The Govt of India is planning to ramp up its massive vaccination program to the age group between 2-18 year olds. The leading vaccine producer firm Bharat Biotech get nod from the Drugs Controller General of India (DCGI) to perform 2 & 3 trials of Covaxin. The trials will take place in 525 subjects at various sites.